Showing results (51-60 of 276) with videos related to

Sort By:
Pageof 28
Diseases of the Colon and Rectum|October 8, 2015
Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor ResectionRyuma Tokunaga, Yasuo Sakamoto, Shigeki Nakagawa, et al.
Journal of Gastroenterology|January 23, 2016
The role of microRNA in esophageal squamous cell carcinomaKazuto Harada, Yoshifumi Baba, Takatsugu Ishimoto, et al.
Annals of Surgery|February 3, 2017
Clinical and Prognostic Features of Patients With Esophageal Cancer and Multiple Primary Cancers: A Retrospective Single-institution StudyYoshifumi Baba, Naoya Yoshida, Koichi Kinoshita, et al.
Annals of Gastroenterological Surgery|November 10, 2021
Overall survival after recurrence in stage I-III colorectal cancer patients in accordance with the recurrence organ site and patternHiroshi Sawayama, Yuji Miyamoto, Yukiharu Hiyoshi, et al.
International Cancer Conference Journal|October 3, 2022
Surgical removal of giant pelvic liposarcoma after preoperative transcatheter arterial embolizationYuto Maeda, Yuji Miyamoto, Yukiharu Hiyoshi, et al.
Esophagus : Official Journal of the Japan Esophageal Society|September 19, 2018
The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study)Yoshihiro Tanaka, Takao Ueno, Naoya Yoshida, et al.
Annals of Gastroenterological Surgery|February 2, 2022
The advanced lung cancer inflammation index is a novel independent prognosticator in colorectal cancer patients after curative resectionTaichi Horino, Ryuma Tokunaga, Yuji Miyamoto, et al.
Anticancer Research|August 2, 2019
Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort StudyYoshihiro Tanaka, Takao Ueno, Naoya Yoshida, et al.
Surgical Case Reports|December 27, 2022
Pathologic complete response after laparoscopic surgery following treatment with nivolumab and ipilimumab for anticancer drug-resistant MSI-high descending colon cancer: a case report and literature reviewHiroshi Sawayama, Yuji Miyamoto, Katsuhiro Ogawa, et al.
In Vivo (Athens, Greece)|June 28, 2021
Human Epidermal Growth Factor Receptor 2-positive Primary Adenocarcinoma in the Cervical Oesophagus: A Case ReportTomo Horinouchi, Naoya Yoshida, Chihiro Matsumoto, et al.
Pageof 28